Patents Assigned to University
  • Publication number: 20170111046
    Abstract: Exemplary embodiments of the present disclosure are directed to a bootstrapping module and logic circuits utilizing the bootstrapping module to compensate for a weak high condition. The bootstrapping module can be implemented using transistors have a single channel type that is the same as the channel type of transistors utilized in the logic circuits such that a truly unipolar circuit can be realized while addressing the weak high problem of such unipolar circuits.
    Type: Application
    Filed: May 29, 2015
    Publication date: April 20, 2017
    Applicant: Yale University
    Inventors: Xaio Sun, Tso-Ping Ma
  • Publication number: 20170109496
    Abstract: In a biological simulation apparatus, an operation unit represents a structure domain where tissues of a biological organ exist by a structure mesh model based on a Lagrange description method and a fluid domain where fluid inside the biological organ exists by an ALE fluid mesh model based on an ALE description method. In a fluid-structure interaction simulation, the operation unit deforms the structure mesh model, and then deforms the ALE fluid mesh model so as to form no gap on a first interface between a domain where a site other than a certain site of the biological organ in the structure domain exists and the fluid domain or no overlap with the structure domain. The operation unit captures a position of a second interface between a domain where the certain site exists and the fluid domain by using the ALE fluid mesh model as a reference.
    Type: Application
    Filed: December 30, 2016
    Publication date: April 20, 2017
    Applicants: FUJITSU LIMITED, The University of Tokyo
    Inventors: Toshiaki HISADA, Seiryo SUGIURA, Takumi WASHIO, Junichi OKADA, Ryozo NAGAI, Taro KARIYA, Masahiro WATANABE, Kohei HATANAKA, Machiko NAKAGAWA, Yoshimasa KADOOKA
  • Publication number: 20170107538
    Abstract: This application discloses the compositions comprising biologically active synthetic nanoparticle constructs and methods of use thereof to modify gene expression including transcriptional activation and transcriptional repression.
    Type: Application
    Filed: August 25, 2014
    Publication date: April 20, 2017
    Applicant: Rutgers, The State University of New Jersey
    Inventors: Ki-Bum LEE, Sahishnu PATEL
  • Publication number: 20170110338
    Abstract: Two-dimensional (2D) transition-metal dichalcogenides have emerged as a promising material system for optoelectronic applications, but their primary figure-of-merit, the room-temperature photoluminescence quantum yield (QY) is extremely poor. The prototypical 2D material, MoS2 is reported to have a maximum QY of 0.6% which indicates a considerable defect density. We report on an air-stable solution-based chemical treatment by an organic superacid which uniformly enhances the photoluminescence and minority carrier lifetime of MoS2 monolayers by over two orders of magnitude. The treatment eliminates defect-mediated non-radiative recombination, thus resulting in a final QY of over 95% with a longest observed lifetime of 10.8±0.6 nanoseconds. Obtaining perfect optoelectronic monolayers opens the door for highly efficient light emitting diodes, lasers, and solar cells based on 2D materials.
    Type: Application
    Filed: October 15, 2016
    Publication date: April 20, 2017
    Applicant: The Regents of the University of California
    Inventors: Matin Amani, Der-Hsien Lien, Daisuke Kiriya, James Bullock, Ali Javey
  • Publication number: 20170107317
    Abstract: A block copolymer includes a first polymer block and a second polymer block having different structures, and one of the first polymer block and the second polymer block has a halogen-substituted structure.
    Type: Application
    Filed: August 1, 2016
    Publication date: April 20, 2017
    Applicants: Samsung Electronics Co., Ltd., Korea University Research and Business Foundation
    Inventors: SEUNGCHUL KWON, Jeongju PARK, Shi-yong YI, Eun Sung KIM, Kyeongmi LEE, Joona BANG, Sanghoon WOO
  • Publication number: 20170108389
    Abstract: A multistage sensing device includes a substrate, a deformable unit, and a sensor unit. The deformable unit has a first body disposed on the substrate, and a second body disposed on the first body and opposite to the substrate. The sensor unit includes a first sensor element and a second sensor element that are disposed in the deformable unit. The first sensor element is disposed between the second sensor element and the substrate. The second sensor element is operable to measure deformation of the second body when an external force is applied to the deformable unit. The first sensor element is operable to measure deformation of the first body when the first body is deformed by the deformation of the second body.
    Type: Application
    Filed: April 15, 2016
    Publication date: April 20, 2017
    Applicant: National Tsing Hua University
    Inventors: Wei-Cheng LAI, Wei-Leun FANG
  • Publication number: 20170108930
    Abstract: The present technology relates to systems, methods and devices for haptically-enabled virtual reality simulation of cerebral aneurysm clipping, wherein a user uses two physical stations during the simulation. The first station is a haptic and augmented reality station, and the second station is a haptic and virtual reality station.
    Type: Application
    Filed: December 23, 2016
    Publication date: April 20, 2017
    Applicants: The Board of Trustees of the University of Illinois, IMMERSIVETOUCH, INC.
    Inventors: P. Pat BANERJEE, Cristian J. LUCIANO, Ali ALARAJ, Fady T. CHARBEL, Jie JIANG
  • Publication number: 20170107190
    Abstract: A compound, or a pharmaceutically acceptable salt thereof, having a structure of wherein Z is aryl or substituted aryl, heteroaryl, or substituted heteroaryl; X is —S—, —S(O)—, or S(O)2—; R20 and R21 are each independently H, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, or halogenated alkyl; one of R22, R23, and R24 is —O— and the others of R22, R23 and R24 are independently —CH2—, or —C(R13)— wherein R13 is alkyl, alkenyl, alkynyl, trialkylsilyl group, or —(CH2)mOR15, wherein R15 is alkyl or an aryl and m is an integer in the range of 1 to 10; and R25 is H, alkyl, substituted alkyl, halogen, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, C1-C3 alkoxy, aryloxy, or —(CH2)qOR17, wherein R17 is alkyl an aryl and q is an integer in the range of 1 to 10.
    Type: Application
    Filed: October 13, 2016
    Publication date: April 20, 2017
    Applicants: University of Pittsburgh - Of the Commonwealth System of Higher Education, Medical University of South Carolina
    Inventors: Peter Wipf, Carol A. Feghali-Bostwick
  • Publication number: 20170107558
    Abstract: An apparatus and method of using an optical coherence elastography (OCE) under acoustic radiation force (ARF) excitation includes the steps of inducing an excitation wave in a blood sample by use of an ultrasound beam from an ultrasonic transducer; measuring an elastic property of the blood sample by use of an optical coherence tomography (OCT) beam transverse to the ultrasound beam to dynamically measure the elastic property of the blood sample during coagulation and assessing the clot formation/dissolution kinetics and strength.
    Type: Application
    Filed: October 13, 2016
    Publication date: April 20, 2017
    Applicant: The Regents of the University of California
    Inventors: Zhongping Chen, Jiang Zhu, Xiangqun Xu
  • Publication number: 20170105963
    Abstract: Apoptosis is generally believed to be a process that requires several hours, in contrast to non-programmed forms of cell death that can occur in minutes. Our findings challenge the time-consuming nature of apoptosis. We describe herein the discovery and characterization of a small molecule, named Raptinal, which initiates intrinsic pathway caspase-dependent apoptosis within minutes, in multiple different cell lines. Comparison to a mechanistically diverse panel of apoptotic stimuli reveals Raptinal-induced apoptosis proceeds with unparalleled speed. The rapid phenotype enabled identification of the critical roles of mitochondrial voltage-dependent anion channel function, mitochondrial membrane potential/coupled respiration, and mitochondrial complex I, III and IV function for apoptosis induction. Use of Raptinal in whole organisms demonstrates its utility to study apoptosis in vivo for a variety of applications.
    Type: Application
    Filed: October 17, 2016
    Publication date: April 20, 2017
    Applicant: The Board of Trustees of the University of Illinois
    Inventors: Paul J. HERGENROTHER, Karson S. PUTT, Rahul PALCHAUDHURI
  • Publication number: 20170108520
    Abstract: The subject invention provides chemical compositions and synthesis strategies to create molecularly imprinted polymers (MIPs) via sol-gel processes. In a specific embodiment, the subject invention utilizes a(n) organic, inorganic, or metallic template analyte to create a hybrid organic-inorganic or inorganic three-dimensional network possessing cavities complementary to the shape, size, and functional orientation of the template molecule or ions. The subject invention further pertains to the use of the novel MIPs as selective solid phase extraction (SPE) sorbents for pre-concentration and clean-up of trace substances in biological and environmental samples. Synthesis of other molecularly imprinted polymers with environmental, pharmaceutical, chemical, clinical, toxicological, and national security implications can be conducted in accordance with the teachings of the subject invention.
    Type: Application
    Filed: October 20, 2016
    Publication date: April 20, 2017
    Applicant: The Florida International University Board of Trustees
    Inventors: Abuzar KABIR, Kenneth G. FURTON
  • Publication number: 20170105989
    Abstract: Compositions and methods are disclosed in embodiments relating to induction of cell death such as in cancer cells. Compounds and related methods for synthesis and use thereof, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells are disclosed. Compounds are disclosed in connection with modification of procaspases such as procaspase-3. In embodiments, compositions are capable of activation of procaspase-3.
    Type: Application
    Filed: December 20, 2016
    Publication date: April 20, 2017
    Applicant: The Board of Trustees of the University of Illinois
    Inventors: Paul J. HERGENROTHER, Karson S. PUTT, Quinn P. PETERSON, Valerie FAKO
  • Patent number: 9623247
    Abstract: One aspect of the present disclosure includes a method for treating chronic or refractory rhinitis in a subject. One step of the method includes implanting a therapy delivery system in the subject so that at least one therapy delivery component of the system is positioned substantially adjacent a target location where modulation of the autonomic nervous system (ANS) is effective to treat chronic or refractory rhinitis. The therapy delivery component includes at least one electrode configured to deliver electric current to the target location. Next, electric current is delivered to the at least one electrode to effect a change in the ANS.
    Type: Grant
    Filed: April 17, 2013
    Date of Patent: April 18, 2017
    Assignee: The Ohio State University
    Inventors: Bradley A Otto, Ali R Rezai
  • Patent number: 9624285
    Abstract: A composition of matter is disclosed which comprises isolated oligomers of human islet amyloid polypeptide (IAPP). Antibodies recognizing same are also disclosed. Use of the composition of matter and the antibodies are also disclosed.
    Type: Grant
    Filed: June 2, 2011
    Date of Patent: April 18, 2017
    Assignee: Ramot a Tel-Aviv University Ltd.
    Inventors: Yaron Bram, Ehud Gazit
  • Patent number: 9624288
    Abstract: Engineered chloride channel receptors, nucleic acids encoding these receptors, expression vectors including these nucleic acids are disclosed herein. Nanoparticles and pharmaceutical compositions including these engineered chloride channel receptors, nucleic acids, and expression vectors are disclosed. The use of these compositions and nanoparticles, such as for the treatment of pain, cystic fibrosis and asthma, is also disclosed.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: April 18, 2017
    Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: Yan Xu, Pei Tang, Tommy Tillman
  • Patent number: 9623084
    Abstract: The present invention provides methods for treating or limiting development of multiple sclerosis by administering angiotensin peptides to a subject with multiple sclerosis or at risk of developing multiple sclerosis.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: April 18, 2017
    Assignee: University of Southern California
    Inventors: Kathleen E. Rodgers, Gere S. DiZerega, Brett Lund, Eve Kelland, Stan Louie
  • Patent number: 9622672
    Abstract: A system for measuring electrical signals in a biological subject includes a variable gain amplifier with a predetermined transfer function that generates amplified signals corresponding to an input from electrical signals in the biological subject over a predetermined range of frequencies and amplification gain levels, an analog to digital converter generating digital data corresponding to the amplified signals, and a signal processing device receiving the digital data for the plurality of amplified signals. The signal processing device applies an inversion filter with another transfer function that is an inverse of the transfer function of the variable gain amplifier to remove an effect of the transfer function from the digital data, and generates an output signal corresponding to the electrical signals in the subject with reference to the filtered digital data.
    Type: Grant
    Filed: June 6, 2014
    Date of Patent: April 18, 2017
    Assignee: Indiana University Research and Technology Corporation
    Inventors: Ken Yoshida, Kevin Mauser, Jan Stavnshoj
  • Patent number: 9624523
    Abstract: The present invention provides a simple culture device that is designed for manufacture and use in areas of limited resources. The device is useful for cell culture in such environments with limited resources because cells grow in paper just as they do in a culture dish. Also provided is a binding assay that employs an activatable dormant bacteriophage carrying a reporter gene to qualitatively or quantitatively detect the presence of a substance of interest in a sample.
    Type: Grant
    Filed: October 29, 2012
    Date of Patent: April 18, 2017
    Assignee: The Governors of the University of Alberta
    Inventors: Ratmir Derda, Maribel Elizabeth Funes Huacca, Simon Ng, Katrina Felicia Tjhung
  • Patent number: 9624305
    Abstract: Methods are provided to manipulate phagocytosis of cancer cells, including e.g. leukemias, solid tumors including carcinomas, etc.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: April 18, 2017
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Siddhartha Jaiswal, Irving L. Weissman, Ravindra Majeti, Mark P. Chao
  • Patent number: 9623243
    Abstract: Methods and apparatus are therefore provided herein for stimulating a desired physiological effect. The methods and apparatus can be used to control micturition, defecation and/or ejaculation. The methods and apparatus also can be used to control pain in the lower pelvic region, for example and without limitation, interstitial cystitis. The methods and apparatus also can be used to increase sexual sensation.
    Type: Grant
    Filed: May 13, 2014
    Date of Patent: April 18, 2017
    Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: Michael B. Chancellor, Changfeng Tai